MTI has been named the Diagnostics and Medical Devices Hub of the BARDA Accelerator Network. Through MedTech Innovator Vantage, MTI will advance next-generation diagnostics and devices that strengthen the diagnosis of health security threats and the response to public health emergencies, selecting up to 10 companies annually for a four-month accelerator with non-dilutive funding. Read the full press release →
As the 700+ companies in our ecosystem grow, they’re looking for exceptional talent to help them. Our Innovator Job Board highlights hundreds of opportunities in every possible discipline a growing company needs to thrive. If you’re looking for your next great opportunity to improve healthcare, check out the listings here!
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination. VANGUARD stands ready to support startups in deploying innovative medical countermeasures that enhance the United States’ readiness for public health emergencies.
BioTools Innovator VANGUARD consists of two programs, a wraparound Accelerator program as part of the core BioTools Innovator annual cohort, and a specialized product Development, Evaluation, and Validation (DEV) funding opportunity. Companies may apply to either or both programs.
Learn more at biotoolsinnovator.org/vanguard
